Treatment of HEPAtic diseases with inNOVAtive solutions.
Hepanova has raised $1.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.
Hepanova's investors include Shenzhen Capital Group, Pudong Innotek.
Hepanova is headquartered in Gaithersburg, United States.
Treatment of HEPAtic diseases with inNOVAtive solutions.
Hepanova is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hepanova — Funding & Investors." VCBacked, April 15, 2023, https://www.vcbacked.co/company/hepanova. Accessed September 11, 2026.
VCBacked. (2023). Hepanova — Funding & Investors. Retrieved September 11, 2026, from https://www.vcbacked.co/company/hepanova
{{cite web |title=Hepanova — Funding & Investors |url=https://www.vcbacked.co/company/hepanova |website=VCBacked |access-date=September 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated